Key Points
- Enforcement Authority: BPOM confirmed it has the power to take immediate legal action against ketamine-laced vapes.
- Ketamine Risks: While ketamine has medical use, it is increasingly abused for recreational and non-medical purposes.
- Product Issues: Ketamine-laced vapes are designed to produce aromas or psychoactive effects.
- BNN Seizures: Authorities intercepted 3 kilograms of ketamine powder from France, 1,860 vape cartridges, and synthetic cannabinoid MDMB-4en-PINACA.
- Spread Trend: BNN warned that new psychoactive substances with narcotic-like effects are spreading rapidly and massively across Indonesia.
- Market Testing: BNN has tested 187 vape samples, with results released for 107, while the rest remain under analysis.
2Firsts, August 28, 2025 —— According to TEMPO, Indonesia’s Food and Drug Monitoring Agency (BPOM) confirmed that it has the authority to take strict enforcement action against vape products containing ketamine. BPOM Chief Taruna Ikrar stated on August 27 at BPOM’s Central Jakarta headquarters that the agency’s regulatory mandate is based not on whether the product is a cigarette or vape, but on whether it contains dangerous substances.
Taruna stressed that although ketamine is used as an anesthetic in medical surgery, its risk of abuse is increasing. It is now often misused as a recreational drug or even for non-medical purposes such as tattooing. BPOM has classified ketamine as a “specific drug” under its new regulations, meaning any vape product testing positive for ketamine may immediately be subject to legal proceedings.
BPOM also noted that some ketamine-laced vapes are designed to generate specific aromas or psychoactive effects, further heightening the risk of misuse. The agency additionally oversees cigarette advertising and mandatory health warnings to ensure public safety.
This statement followed actions by the National Narcotics Agency (BNN). Recently, BNN uncovered counterfeit ketamine used in vape cartridges. In one case, officers seized 80 milliliters of synthetic cannabinoid MDMB-4en-PINACA and one vape pod shipped from Malaysia to Pandeglang, Banten. In another case, they intercepted 3 kilograms of powdered ketamine from France, allegedly intended for vape liquid production, along with 1,860 vape cartridges.
In a statement issued on August 22, BNN warned that the spread of new psychoactive substances with narcotic-like effects is expanding rapidly and massively in Indonesia. To address the issue, BNN has collected 187 vape samples from the market for testing; results for 107 samples have been released, while the remainder are still undergoing laboratory analysis.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
